{"nodes":[{"id":"PRMT hypermethylation","type":"process"},{"id":"ADMA","type":"biomarker"},{"id":"Alzheimer's disease","type":"disease"},{"id":"TDP-43 methylation","type":"process"},{"id":"TDP-43 splicing dysfunction","type":"mechanism"},{"id":"neurodegeneration","type":"disease"},{"id":"narrow therapeutic window","type":"process"},{"id":"processed","type":"sentinel"},{"id":"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614","type":"debate_session_causal"},{"id":"HSP90","type":"gene","has_wiki":true,"wiki_url":"/wiki/proteins-hsp90","wiki_entity":"HSP90"},{"id":"PRMT hypomethylation","type":"process"},{"id":"MAPK14/PRMT1","type":"gene"},{"id":"HSP27","type":"gene","has_wiki":true,"wiki_url":"/wiki/proteins-hsp27-protein","wiki_entity":"HSP27"},{"id":"HSPB1","type":"gene","has_wiki":true,"wiki_url":"/wiki/genes-hsp27","wiki_entity":"HSPB1"},{"id":"PRMT inhibitor clinical translation","type":"process"},{"id":"elevated plasma ADMA","type":"biomarker"},{"id":"TDP-43 splicing activity","type":"process"},{"id":"methylation dosing paradox","type":"mechanism"},{"id":"PRMTs","type":"protein"},{"id":"ADMA-guided adaptive dosing","type":"process"},{"id":"PRMT activity","type":"process"},{"id":"compartment-selective PRMT inhibition","type":"process"},{"id":"nuclear TDP-43 methylation","type":"process"},{"id":"nitric oxide synthases","type":"protein"}],"edges":[{"source_id":"MAPK14/PRMT1","source_type":"gene","target_id":"neurodegeneration","target_type":"disease","relation":"promoted: p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methy","evidence_strength":0.615,"evidence_sources":"[\"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651\", \"{'claim': 'P38\\u03b1 phosphorylation and PRMT1 methylation have opposing roles in TDP-43 proteinopathy - PRMT1-mediated methylation opposes p38\\u03b1 phosphorylation in driving TDP-43 pathology', 'pmid': '39817908'}\", \"{'claim': \\\"P38\\u03b1 inhibitors (neflamapimod) are in Phase 2 trials for Alzheimer's and DLB with demonstrated CNS penetration and favorable safety profile\\\", 'pmid': 'NCT05869669'}\", \"{'claim': \\\"mRNA 3'-UTR binding pathway enrichment with TARDBP (GO:0003730, p=2.73e-08) supports the methylation-phosphorylation axis in RNA metabolism\\\", 'pmid': '39817908'}\", \"{'claim': 'Neflamapimod showed reversal of synaptic dysfunction in mild AD at 40mg BID oral dosing with good tolerability', 'pmid': 'NCT05869669'}\", \"{'claim': 'Methylosome co-localization of PRMT1/PRMT5 with TARDBP confirmed by STRING analysis (GO:0034709, p=9.82e-06)', 'pmid': '39817908'}\"]","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-13T05:27:54-07:00","edge_type":"promoted_hypothesis","source_canonical_id":"mapk14_prmt1","target_canonical_id":"ent-rese-6f3dc74d","epistemic_status":"speculative","trust_score":null,"confidence_interval":null,"trust_computed_at":null,"id":"promoted-h-ccc05373","trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"HSP27","source_type":"gene","target_id":"HSPB1","target_type":"gene","relation":"co_discussed","evidence_strength":0.4,"evidence_sources":"hypothesis:h-ff0d545d","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-16T18:27:54.037460-07:00","edge_type":"hypothesis_cooccurrence","source_canonical_id":"ent-gene-bb7f16c8","target_canonical_id":"ent-gene-8a39255c","epistemic_status":"speculative","trust_score":null,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"HSP90","source_type":"gene","target_id":"HSPB1","target_type":"gene","relation":"co_discussed","evidence_strength":0.4,"evidence_sources":"hypothesis:h-ff0d545d","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-16T18:27:54.037460-07:00","edge_type":"hypothesis_cooccurrence","source_canonical_id":"Hsp90","target_canonical_id":"ent-gene-8a39255c","epistemic_status":"speculative","trust_score":null,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"PRMT activity","source_type":"process","target_id":"ADMA","target_type":"biomarker","relation":"causes","evidence_strength":0.9,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.9,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"ADMA","source_type":"biomarker","target_id":"PRMTs","target_type":"protein","relation":"inhibits","evidence_strength":0.9,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.9,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"ADMA","source_type":"biomarker","target_id":"nitric oxide synthases","target_type":"protein","relation":"inhibits","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"PRMT activity","source_type":"process","target_id":"TDP-43 methylation","target_type":"process","relation":"regulates","evidence_strength":0.9,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.9,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"TDP-43 methylation","source_type":"process","target_id":"TDP-43 splicing activity","target_type":"process","relation":"modulates","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"TDP-43 splicing dysfunction","source_type":"mechanism","target_id":"neurodegeneration","target_type":"disease","relation":"causes","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"PRMT hypomethylation","source_type":"process","target_id":"neurodegeneration","target_type":"disease","relation":"causes","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"PRMT hypermethylation","source_type":"process","target_id":"neurodegeneration","target_type":"disease","relation":"causes","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"elevated plasma ADMA","source_type":"biomarker","target_id":"Alzheimer's disease","target_type":"disease","relation":"associated_with","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"ADMA-guided adaptive dosing","source_type":"process","target_id":"methylation dosing paradox","target_type":"mechanism","relation":"modulates","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"narrow therapeutic window","source_type":"process","target_id":"PRMT inhibitor clinical translation","target_type":"process","relation":"prevents","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"compartment-selective PRMT inhibition","source_type":"process","target_id":"nuclear TDP-43 methylation","target_type":"process","relation":"modulates","evidence_strength":0.7,"evidence_sources":"{\"debate_session_id\": \"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.967268-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"speculative","trust_score":0.7,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null},{"source_id":"sess_SDA-2026-04-12-gap-debate-20260410-113051-5dce7651_20260412-225614","source_type":"debate_session_causal","target_id":"processed","target_type":"sentinel","relation":"causal_extracted","evidence_strength":0.0,"evidence_sources":"{\"task_id\": \"72f50712-2194-475b-86bd-45cb6df6b175\"}","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-28T13:32:35.979259-07:00","edge_type":"debate_extracted","source_canonical_id":null,"target_canonical_id":null,"epistemic_status":"internal","trust_score":0.0,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}","causal_quality_scorecard":null}],"pagination":{"limit":5000,"offset":0,"total_edges":16,"total_nodes":24,"has_more":false}}